Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Dermatologic Therapy
|
August 15, 2020
Clinically atypical cutaneous mycobacteriosis: A therapeutic challenge
Teresa Ródenas-Herranz, Laura Linares-Gonzalez, Leopoldo Muñoz-Medina, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)
|
June 1, 2020
Hemophagocytic lymphohistiocytosis associated with Leishmania: A hidden passenger in endemic areas
Jon Badiola, Leopoldo Muñoz-Medina, José Luis Callejas, et al.
AIDS (London, England)
|
May 20, 2014
Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes
David Vinuesa, Jorge Parra-Ruiz, Natalia Chueca, et al.
Revista Espanola De Geriatria Y Gerontologia
|
June 23, 2020
[Evolution and treatment of storm cytoquine syndrome associated to SARS-CoV-2 infection among octogenarians]
José Luis Callejas Rubio, Ismael Aomar Millán, Manuela Moreno Higueras, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
June 3, 2015
Nebulized medication is not associated with nosocomial infections. A pilot study
David Vinuesa, Violeta Ramos, Alejandro Peña, et al.
International Journal of STD & AIDS
|
November 5, 2024
<i>Mycobacterium avium</i> complex (MAC) infection in severely immunocompromised people living with HIV: Findings from a five-year cohort
María Del Rocío Fernández-Díaz, Naya Faro-Miguez, María Aguilera-Franco, et al.
Viruses
|
December 23, 2022
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV
Carmen Hidalgo-Tenorio, David Vinuesa, Coral García-Vallecillos, et al.
Journal of Clinical Microbiology
|
February 8, 2013
Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter
Marta Álvarez Estévez, Natalia Chueca Porcuna, Vicente Guillot Suay, et al.
International Journal of Clinical Practice
|
October 31, 2018
Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score
María Ruiz-Ruigómez, Carlos Dueñas, Cristina Hernandez, et al.
The Pediatric Infectious Disease Journal
|
November 3, 2023
Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain
Cristina Epalza, Ana Valadés-Alcaraz, José María González-Alba, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Dermatologic Therapy
|
August 15, 2020
Clinically atypical cutaneous mycobacteriosis: A therapeutic challenge
Teresa Ródenas-Herranz, Laura Linares-Gonzalez, Leopoldo Muñoz-Medina, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)
|
June 1, 2020
Hemophagocytic lymphohistiocytosis associated with Leishmania: A hidden passenger in endemic areas
Jon Badiola, Leopoldo Muñoz-Medina, José Luis Callejas, et al.
AIDS (London, England)
|
May 20, 2014
Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes
David Vinuesa, Jorge Parra-Ruiz, Natalia Chueca, et al.
Revista Espanola De Geriatria Y Gerontologia
|
June 23, 2020
[Evolution and treatment of storm cytoquine syndrome associated to SARS-CoV-2 infection among octogenarians]
José Luis Callejas Rubio, Ismael Aomar Millán, Manuela Moreno Higueras, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
June 3, 2015
Nebulized medication is not associated with nosocomial infections. A pilot study
David Vinuesa, Violeta Ramos, Alejandro Peña, et al.
International Journal of STD & AIDS
|
November 5, 2024
<i>Mycobacterium avium</i> complex (MAC) infection in severely immunocompromised people living with HIV: Findings from a five-year cohort
María Del Rocío Fernández-Díaz, Naya Faro-Miguez, María Aguilera-Franco, et al.
Viruses
|
December 23, 2022
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV
Carmen Hidalgo-Tenorio, David Vinuesa, Coral García-Vallecillos, et al.
Journal of Clinical Microbiology
|
February 8, 2013
Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter
Marta Álvarez Estévez, Natalia Chueca Porcuna, Vicente Guillot Suay, et al.
International Journal of Clinical Practice
|
October 31, 2018
Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score
María Ruiz-Ruigómez, Carlos Dueñas, Cristina Hernandez, et al.
The Pediatric Infectious Disease Journal
|
November 3, 2023
Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain
Cristina Epalza, Ana Valadés-Alcaraz, José María González-Alba, et al.
Page
of 2